NCT01649284 - Afatinib Expanded Access Program | Biotech Hunter

Timeline

Start Date

July 31, 2012

Primary Completion Date

March 31, 2014

Study Completion Date

March 31, 2014

Conditions

Carcinoma, Non-Small-Cell Lung

Interventions

DRUG

afatinib

40, 30, and 20 mg film-coated tablets

Trial Locations (66)

Unknown

1200.45.004 Boehringer Ingelheim Investigational Site, Mobile

1200.45.116 Boehringer Ingelheim Investigational Site, Goodyear

1200.45.057 Boehringer Ingelheim Investigational Site, Hot Springs

1200.45.078 Boehringer Ingelheim Investigational Site, Anaheim

1200.45.114 Boehringer Ingelheim Investigational Site, Burbank

1200.45.123 Boehringer Ingelheim Investigational Site, Glendale

1200.45.115 Boehringer Ingelheim Investigational Site, Lakewood

1200.45.117 Boehringer Ingelheim Investigational Site, Long Beach

1200.45.102 Boehringer Ingelheim Investigational Site, Monterey

1200.45.091 Boehringer Ingelheim Investigational Site, Pleasant Hill

1200.45.098 Boehringer Ingelheim Investigational Site, Pleasant Hill

1200.45.006 Boehringer Ingelheim Investigational Site, Ranco Cucamonga

1200.45.003 Boehringer Ingelheim Investigational Site, Southington

1200.45.007 Boehringer Ingelheim Investigational Site, Stamford

1200.45.026 Boehringer Ingelheim Investigational Site, Hollywood

1200.45.097 Boehringer Ingelheim Investigational Site, Hollywood

1200.45.017 Boehringer Ingelheim Investigational Site, Jacksonville

1200.45.058 Boehringer Ingelheim Investigational Site, Jacksonville

1200.45.016 Boehringer Ingelheim Investigational Site, Lakeland

1200.45.103 Boehringer Ingelheim Investigational Site, Miami Beach

1200.45.037 Boehringer Ingelheim Investigational Site, Orlando

1200.45.056 Boehringer Ingelheim Investigational Site, Port Saint Lucie

1200.45.119 Boehringer Ingelheim Investigational Site, Titusville

1200.45.095 Boehringer Ingelheim Investigational Site, Alpharetta

1200.45.029 Boehringer Ingelheim Investigational Site, Athens

1200.45.042 Boehringer Ingelheim Investigational Site, Macon

1200.45.121 Boehringer Ingelheim Investigational Site, Valdosta

1200.45.024 Boehringer Ingelheim Investigational Site, Decatur

1200.45.009 Boehringer Ingelheim Investigational Site, Evanston

1200.45.099 Boehringer Ingelheim Investigational Site, Peoria

1200.45.040 Boehringer Ingelheim Investigational Site, Waterloo

1200.45.041 Boehringer Ingelheim Investigational Site, Wichita

1200.45.083 Boehringer Ingelheim Investigational Site, Marrero

1200.45.087 Boehringer Ingelheim Investigational Site, Metairie

1200.45.019 Boehringer Ingelheim Investigational Site, Columbia

1200.45.039 Boehringer Ingelheim Investigational Site, Rockville

1200.45.053 Boehringer Ingelheim Investigational Site, Ann Arbor

1200.45.046 Boehringer Ingelheim Investigational Site, Detroit

1200.45.100 Boehringer Ingelheim Investigational Site, Jackson

1200.45.067 Boehringer Ingelheim Investigational Site, St Louis

1200.45.071 Boehringer Ingelheim Investigational Site, Billings

1200.45.021 Boehringer Ingelheim Investigational Site, Omaha

1200.45.066 Boehringer Ingelheim Investigational Site, Freehold

1200.45.105 Boehringer Ingelheim Investigational Site, Albuquerque

1200.45.080 Boehringer Ingelheim Investigational Site, Brooklyn

1200.45.068 Boehringer Ingelheim Investigational Site, Fresh Meadows

1200.45.051 Boehringer Ingelheim Investigational Site, New York

1200.45.092 Boehringer Ingelheim Investigational Site, New York

1200.45.001 Boehringer Ingelheim Investigational Site, Charlotte

1200.45.086 Boehringer Ingelheim Investigational Site, Bismarck

1200.45.048 Boehringer Ingelheim Investigational Site, Minot

1200.45.090 Boehringer Ingelheim Investigational Site, Canton

1200.45.005 Boehringer Ingelheim Investigational Site, Columbus

1200.45.089 Boehringer Ingelheim Investigational Site, Tulsa

1200.45.094 Boehringer Ingelheim Investigational Site, Portland

1200.45.020 Boehringer Ingelheim Investigational Site, Hershey

1200.45.096 Boehringer Ingelheim Investigational Site, Johnstown

1200.45.060 Boehringer Ingelheim Investigational Site, Philadelphia

1200.45.085 Boehringer Ingelheim Investigational Site, Pottstown

1200.45.120 Boehringer Ingelheim Investigational Site, Rapid City

1200.45.049 Boehringer Ingelheim Investigational Site, Cookeville

1200.45.113 Boehringer Ingelheim Investigational Site, El Paso

1200.45.045 Boehringer Ingelheim Investigational Site, Fairfax

1200.45.076 Boehringer Ingelheim Investigational Site, Seattle

1200.45.093 Boehringer Ingelheim Investigational Site, Charleston

1200.45.125 Boehringer Ingelheim Investigational Site, Wausau